Denton John Russel
SEC CIK 2071923 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CAI | Caris Life Sciences, Inc. | See Remarks | 174.9K | $258.3K | $238.6K | 7 | 2025-03-03 | 2026-09-22 |
Most active insiders at CAI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Spetzler David Baxley | Pres | $9,540 | $14.83M |
| 2 | Brille Brian J | See Remarks, Dir | — | $12.13M |
| 3 | Power Luke Thomas | See Remarks | — | $1.65M |
| 4 | HALBERT JON | Dir | $990.1K | — |
| 5 | Vacirca Jeff L | Dir | $501.4K | — |
| 6 | Denton John Russel | See Remarks | $100.8K | $238.6K |
| 7 | Fredrickson David Paul | Dir | — | — |
| 8 | Minor Lloyd | Dir | — | — |
| 9 | Gilliam Joseph E | Dir | — | — |
| 10 | Knowles Jonathan Kenneth Charles | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-23 17:06 | 2026-09-22 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | S - Sale | $31.82 | -7,500 | 174.9K | -4% | -$238.6K | |
| 2026-05-18 16:23 | 2026-05-15 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | F - Tax | $15.25 | -6,047 | 181.5K | -3% | -$92.2K | |
| 2026-03-10 | 2026-03-06 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | A - Grant | $0.00 | +64.0K | 187.6K | +52% | $0 | |
| I | 2025-11-10 | 2025-11-07 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | P - Purchase | $24.09 | +4,184 | 9,184 | +84% | +$100.8K |
| D | 2025-06-23 | 2025-06-20 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | P - Purchase | $21.00 | +7,500 | 123.6K | +6% | +$157.5K |
| D | 2025-06-23 | 2025-03-03 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | D - Sale to Iss | $18.60 | -238.2K | 16.8K | -93% | -$4.43M |
| D | 2025-06-23 | 2025-06-18 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | A - Grant | $0.00 | +99.3K | 116.1K | +592% | $0 |
Purchase Sale Sale after option exercise All abbreviations